L. H. Chen

The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells.

P. Hersey, H. Tseng, L. H. Chen, 2012, Carcinogenesis.

Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.

Nizar M. Mhaidat, P. Hersey, L. H. Chen, 2007, Cancer research.

Cellular protein kinase C isozyme regulation by exogenously delivered physiological disulfides--implications of oxidative protein kinase C regulation to cancer prevention.

L. H. Chen, C. O'Brian, F. Chu, 2003, Carcinogenesis.

Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein.

P. Hersey, L. H. Chen, C. Jiang, 2008, Cancer research.

Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response.

P. Hersey, L. H. Chen, C. Jiang, 2007, Carcinogenesis.

Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis.

P. Hersey, L. H. Chen, C. Jiang, 2007, Cancer research.

Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells

P. Hersey, L. H. Chen, C. Jiang, 2008, Anti-cancer drugs.